Pharmacological potency of R- and S-3′-hydroxy-Δ9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity
- 1 July 1984
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 21 (1) , 61-65
- https://doi.org/10.1016/0091-3057(84)90131-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Drugs related to tetrahydrocannabinolMedicinal Research Reviews, 1983
- 3'-Hydroxy- and (.+-.)-3',11-dihydroxy-.DELTA.9-tetrahydrocannabinol: (THC) biologically active metabolites of .DELTA.9-tetrahydrocannabinolJournal of Medicinal Chemistry, 1982
- IDENTIFICATION OF INVITRO METABOLITES OF DELTA-1-TETRAHYDROCANNABINOL FORMED BY HUMAN LIVERS1982
- Plasma and Brain Levels of Δ6-THC and Seven Monooxygenated Metabolites Correlated to the Cataleptic Effect in the MouseActa Pharmacologica et Toxicologica, 1980
- Evidence for the existence of specific cannabinoid binding sitesLife Sciences, 1978
- H-3-DELTA9-TETRAHYDROCANNABINOL TISSUE AND SUBCELLULAR-DISTRIBUTION IN CENTRAL NERVOUS-SYSTEM AND TISSUE DISTRIBUTION IN PERIPHERAL ORGANS OF TOLERANT AND NONTOLERANT DOGS1976
- Metabolism of Δ1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolismJournal of Pharmacy and Pharmacology, 1975
- Relative pharmacological potency in mice of optical isomers of Δ1-tetrahydrocannabinolBiochemical Pharmacology, 1974
- (−)-Δ8-tetrahydrocannabinol: Two novel in vitro metabolitesCellular and Molecular Life Sciences, 1971
- A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS1949